@article{9cf395fa8fc04abb97c39951257047e3,
title = "Fecal microbiota transplantation for recurrent clostridium difficile infection and other conditions in children: A joint position paper from the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition",
abstract = "Fecal microbiota transplantation (FMT) is becoming part of the treatment algorithms against recurrent Clostridium difficile infection (rCDI) both in adult and pediatric gastroenterology practice. With our increasing recognition of the critical role the microbiome plays in human health and disease, FMT is also being considered as a potential therapy for other disorders, including inflammatory bowel disease (Crohn disease, ulcerative colitis), graft versus host disease, neuropsychiatric diseases, and metabolic syndrome. Controlled trials with FMT for rCDI have not been performed in children, and numerous clinical and regulatory considerations have to be considered when using this untraditional therapy. This report is intended to provide guidance for FMT in the treatment of rCDI in pediatric patients.",
keywords = "child, Clostridium difficile, fecal, fecal transplantation, microbiome, microbiota, pediatric",
author = "Davidovics, {Zev H.} and Sonia Michail and Nicholson, {Maribeth R.} and Kociolek, {Larry K.} and Nikhil Pai and Richard Hansen and Tobias Schwerd and Aldo Maspons and Raanan Shamir and Hania Szajewska and Nikhil Thapar and {De Meij}, Tim and Alexis Mosca and Yvan Vandenplas and Kahn, {Stacy A.} and Richard Kellermayer",
note = "Funding Information: The authors gratefully acknowledge the guidance and support of Dr Andrew Grossman in developing, drafting, and revising this article. The authors also gratefully acknowledge the following: Cures Within Reach (PI: Kahn), The Neil and Anna Rasmussen Foundation (PI: Kahn), and the Hamel Family (PI: Kahn), CTSA KL2 award, No.UL1 TR000445 (PI Hartmann), Wagner Family led Gutsy Kids Fund (PI: Kellermayer), and the Klaasmeyer family funds for Primary Sclerosing Cholangitis research (PI: Kellermayer). Publisher Copyright: {\textcopyright} 2019 EDP Sciences. All rights reserved.",
year = "2019",
month = jan,
doi = "10.1097/mpg.0000000000002205",
language = "English",
volume = "68",
pages = "130--143",
journal = "Journal of Pediatric Gastroenterology and Nutrition",
issn = "0277-2116",
publisher = "Lippincott Williams and Wilkins Ltd.",
number = "1",
}
